第73届美国糖尿病协会科学年会

ADA2013:同济大学医学院曲伸发现25羟维生素D可改善血糖控制

作者:desperado-c    2013-07-03
字体大小:

 

为了评估在中国2型糖尿病患者中,25羟维生素D[25(OH)D]的状态,以及其与葡萄糖代谢的关系。来自同济大学医学院的曲伸教授及其团队进行了一项研究,该研究发现维生素D缺乏在中国糖尿病人群中非常普遍。25(OH)D水平与血糖和稳态模型评估的胰岛素抵抗(HOMA–IR)呈负相关,暗示25(OH)D可以通过改善胰岛素抵抗降低血糖。

该研究中,在一个来自中国上海、被诊断为2型糖尿病的患者的横断面样本(592例男性和543例女性,年龄30–80岁)中测量血浆25(OH)D。测量空腹血糖、空腹胰岛素、糖化血红蛋白(HbA1c)。根据上述参数计算稳态模型评估的β细胞功能(HOMA–β)和HOMA–IR。

该研究结果表明,血浆25(OH)D的几何均数为52nmol/l,且维生素D缺乏[25(OH)D<50nmol/l]和维生素D不足[50nmol/l≤25(OH)D<75nmol/l]的比例分别为53.1%和25.8%。25(OH)D与HbA1c、空腹血糖和HOMA-IR呈显著负相关(r=-0.066,p<0.05; r=-0.122,p<0.01; r=-0.091,p<0.01)。

该研究发现,维生素D缺乏在中国糖尿病人群中非常普遍。25(OH)D水平与血糖和HOMA-IR呈负相关,暗示25(OH)D可以通过改善胰岛素抵抗降低血糖。需要前瞻性随机临床试验确定25(OH)D在调节葡萄糖代谢中的作用。

 

To evaluate the status of 25-hydroxyvitamin D [25(OH)D] and its association with glucose metabolism in the type two diabetes Chinese patients.

Plasma 25(OH)D was measured in a cross-sectional sample of 592 men and 543 women aged 30-80 years from Shanghai Chinese patients who have been diagnosed with type two diabetes mellitus. Fasting plasma glucose insulin A1C were measured. Homeostasis model assessment of β cell function (HOMA-β) and homeostasis model assessment of insulin resistance (HOMA-IR) were calculated based on the above parameters.

The geometric mean of plasma 25(OH)D was 52 nmol/l and percentages of vitamin D deficiency [25(OH)D <50 nmol/l] and insufficiency [50 ≤ 25(OH)D <75 nmol/l] were 53.1% and 25.8% respectively. Significant inverse associations existed between 25(OH)D with A1C and fasting plasma glucose and HOMA-IR(r=-0.066 p<0.05; r=-0.122 p<0.01; r=-0.091 p<0.01).

Vitamin D deficiency is common in diabetic Chinese population. 25(OH)D level is significantly negatively associated with plasma glucose and HOMA-IR implying 25(OH)D might lower glucose through improve insulin resistance . Prospective randomized clinical trials are warranted to determine the role of 25(OH)D in regulating glucose metabolism.

 

编辑: 葛根    来源:丁香园

网友评论

ADA是美国糖尿病学会 (Americn Diabetos Association)的缩写,美国糖尿病协会县美国重要的非赢利性卫生姐织,旨在提供有关糖尿病的研究进展和信息,促进糖尿病的科研、教育、诊疗等,关注一切与糖尿病有关的事务。